Clinical Trial Update: This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating BI 425809 with computer-based brain training to improve mental function in schizophrenia has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• BI 425809 (BI-425809)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2023-11-18